Table 1.
Baseline characteristics | MI Study (ITRAQ) | ASCVD Study (MRM and Depletion MRM) |
||
---|---|---|---|---|
Controls (n=135) |
Cases (n=135) |
Controls (n=336) |
Cases (n=336) |
|
Age, years * | 65±9 | 65±9 | 65±9 | 65±9 |
Female (%) * | 34 | 34 | 30 | 30 |
Smoking, current (%) * | 24 | 24 | 17 | 17 |
Statin use (%)* | 19 | 19 | 22 | 22 |
Hypertension treatment (%) | 37 | 47 | 35 | 49 |
Diabetes, prevalent (%) | 7 | 28 | 9 | 27 |
Lipid lowering therapy (%) | 20 | 21 | 24 | 27 |
Systolic blood pressure, mm Hg | 131±18 | 137±18 | 131±19 | 137±20 |
Total cholesterol, mg/Dl | 198±34 | 205±44 | 197±33 | 203±44 |
HDL cholesterol, mg/Dl | 47±15 | 45±12 | 49±15 | 45±14 |
BMI, kg/m2 | 27.8±4.4 | 28.8±4.8 | 27.6±4.4 | 29.0±4.9 |
Presented are mean±SD for continuous traits, or % for dichotomous traits
Matching factors